window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 31, 2026

  • News
  • About Us
Contact Us

Oncology

  • Clinical studies,Drug Development,Oncology,Precision medicine,Research & Development

    Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer

    Researchers at City St George’s, University of London have identified [...]

    January 29, 2026
  • Diagnostics,Facilities and infrastructure,Oncology,Precision medicine,Research & Development

    Vortex Biotech opens new laboratory at Manchester Science Park to expand liquid biopsy development

    Vortex Biotech Holdings has opened a new laboratory facility at [...]

    January 27, 2026
  • Clinical Development,Clinical Trials,Healthcare leadership,Movers & Shakers,Oncology,Patient Centricity

    START appoints Dr Navid Hafez as director of clinical research at new Los Angeles site

    The START Center for Cancer Research has appointed Dr Navid [...]

    January 27, 2026
  • Clinical Development,Clinical Trials,Immunology,Oncology,Pharmaceuticals and therapeutics

    Scancell clears FDA IND for iSCIB1+ registrational Phase 3 trial in advanced melanoma

    Scancell Holdings has announced that the U.S. Food and Drug [...]

    January 26, 2026
  • Artificial Intelligence,Biotech,Clinical Trials,Diagnostics,Oncology,Precision medicine,Research & Development,Technology and platforms

    SpotitEarly announces strategic partnership with Fox Chase Cancer Center to advance early cancer detection

    SpotitEarly has formed a strategic partnership with Fox Chase Cancer [...]

    January 21, 2026
  • Central Nervous System,Clinical Development,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Regulatory Affairs

    Accord Healthcare disappointed as people with ES-SCLC in Scotland denied access to serplulimab

    Patients in Scotland living with extensive-stage small cell lung cancer [...]

    January 23, 2026
  • Clinical Development,Clinical Trials,Movers & Shakers,Oncology,Research & Development

    Syncromune appoints Stephen Dale as Chief Medical Officer

    Syncromune has appointed Stephen Dale as chief medical officer, strengthening [...]

    January 14, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Clinical Trials,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Bicara announces Phase 3 optimal dose for ficerafusp alfa and provides 2026 corporate outlook

    Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

    January 13, 2026
  • Clinical Development,Clinical Trials,Drug approval,Oncology,Pharmaceuticals and therapeutics,Rare Diseases,Regulatory Affairs

    FDA accepts Merck NDA for pimicotinib in tenosynovial giant cell tumor

    Merck has announced that the US Food and Drug Administration [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Drug Development,Oncology,Pharmaceuticals and therapeutics,Technology and platforms

    Bio‑Sourcing and Zerion Pharma collaborate on first oral HER2 monoclonal antibody

    Bio‑Sourcing and Zerion Pharma have joined forces to develop the [...]

    January 12, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Evestia Clinical acquires ICRC-Weyer to expand full-service clinical research in Europe
    Categories: Biotech, CDMOs & Manufacturing, Clinical Development, Clinical Trials, Partnerships & Funding
  • Mental health systems strain as demand and funding shifts drive push for multimodal care
    Categories: Digital Health, Healthcare leadership, Medical devices, Mental health, Regulatory Affairs
  • Nine-gene signature linked to lapatinib resistance in HER2-positive breast cancer
    Categories: Clinical studies, Drug Development, Oncology, Precision medicine, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top